HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
$2.85
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$2.85
Sarado: Abr 25, 7:57:10 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$2.94
Sakop ng araw
$2.84 - $3.04
Sakop ng taon
$0.82 - $3.04
Market cap
222.39M USD
Average na Volume
750.02K
P/E ratio
78.79
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 18.22M | 73.74% |
Gastos sa pagpapatakbo | 7.12M | -1.68% |
Net na kita | 6.49M | 207.45% |
Net profit margin | 35.65 | 161.85% |
Kita sa bawat share | — | — |
EBITDA | 7.54M | 242.27% |
Aktuwal na % ng binabayarang buwis | 11.24% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 34.83M | -21.84% |
Kabuuang asset | 73.42M | -13.05% |
Kabuuang sagutin | 30.21M | -40.62% |
Kabuuang equity | 43.21M | — |
Natitirang share | 78.03M | — |
Presyo para makapag-book | 5.16 | — |
Return on assets | 26.70% | — |
Return on capital | 41.50% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 6.49M | 207.45% |
Cash mula sa mga operasyon | 3.99M | 11.02% |
Cash mula sa pag-invest | -15.32M | -4,379.53% |
Cash mula sa financing | 3.63M | — |
Net change in cash | -7.65M | -337.10% |
Malayang cash flow | 1.67M | -71.01% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
213
